At-home testing Tasso focuses on at-home blood collection and partnerships to enable remote clinical research and diagnostics, presenting a clear opportunity to sell integrated at-home testing solutions, partnerships with CROs, and remote study platforms.

Clinical partnerships Ongoing collaborations with ARUP, Neurogen Biomarking, SheMed, and Thriva indicate a strong channel for co-developed products and large-scale deployments in research and patient monitoring, suggesting sales plays around joint development and white-label offerings.

Expansion momentum Recent recognition and initiatives, including EY Entrepreneur of the Year finalist status and participation in high-profile events such as the Olympic Winter Games, signal growth trajectory and credibility useful in expanding to larger healthcare systems and research networks.

Doping and athlete programs Participation with InnoVero for anti-doping technology at major events demonstrates a niche in secure, painless collection for regulated environments, offering opportunities with sports leagues, events, and anti-doping sponsors.

Sustainability and accessibility A patient-centric, convenient, virtually painless approach aligns with trends toward increasing patient engagement and accessibility, enabling upsell of turnkey remote phlebotomy programs to clinics, universities, and consumer health platforms.